Humboldt Fund is a venture capital fund that supports innovative, early-stage companies by investing in the biotech revolution. Synthetic biology is poised to transform the way we make chemicals, materials, foods and medicines. At Humboldt Fund, we identify and invest in pioneers of engineering, physical sciences and life sciences to bring emerging biotech enterprises to a global market. Together we explore, discover and create new technologies that disrupt global conventions and solve the critical issues of our world, while creating value and prosperity.